Costly GLP-1 drugs such as Ozempic, Wegovy, Mounjaro and Zepbound could be covered under the new plan.
www.marketwatch.com
#Weightloss #drugs #covered #Medicare #Medicaid #experimental #program
Related Posts

Why stocks like Salesforce, Adobe may still lag
CNBC’s Jim Cramer on Thursday marveled at the divergent fates of technology stocks — the hardware winners and software losers…

Jobs, profit-taking and 2 other things that drove the stock market this week
The very public implosion of President Donald Trump and Elon Musk ‘s alliance may have captivated Wall Street this week,…
Here’s What to Expect From Arthur J. Gallagher’s Next Earnings Report
Arthur J_ Gallagher & Co_ billboard- by monticello via Shutterstock Rolling Meadows, Illinois-based Arthur J. Gallagher & Co. (AJG) provides…

